Non-Melanoma Skin Cancers Coverage from Every Angle

Recent News

Role of Oncogenic Molecule in Pathogenesis of Cutaneous Squamous Cell Carcinoma
A Core Outcomes Set for Actinic Keratosis Under Study
SITC 2019: Using Activated Natural Killer Cells to Treat Merkel Cell Carcinoma
Vismodegib Discontinuation and Survival in Locally Advanced Basal Cell Carcinoma
Rare Cases of Perianal and Perineal Keratoacanthomas Reported
Advanced Non-Melanoma Skin Cancer: Systemic Treatment Update
Case Series on Sternectomy for Late-Stage Non-Melanoma Skin Cancer
FDA Approves Radiation Device for Skin Cancer and Other Lesions
Teaching Skin Cells to Treat Skin Cancer: Focus on Blocking Key Regulator
Novel 3D-Printed Bachytherapy Device for Non-Melanoma Skin Cancer
Characterizing the Genome in Merkel Cell Carcinoma
New European Guidelines for Diagnosis and Treatment of Basal Cell Carcinoma
Ohio University Receives $1.7M Grant for Research on Non-Melanoma Skin Cancers
Many Americans Unfamiliar With Cutaneous Squamous Cell Carcinoma, Survey Finds
Can Food Sources of Vitamin A Lower the Risk of Skin Cancer?
Newer Treatment Options Under Study for Advanced Cutaneous T-Cell Lymphomas
Targeting the Tumor Microenvironment in Cutaneous Squamous Cell Carcinoma
Use of F-18 FDG-PET/CT in Initial Staging of Cutaneous Squamous Cell Carcinoma
Novel Monoclonal Antibody Under Study for Peripheral T-Cell Lymphomas
FDA Accepts sBLAs for 6-Week Dosing Schedule of Pembrolizumab for Merkel Cell Carcinoma
Cemiplimab-rwlc Approved for Advanced Cutaneous Squamous Cell Carcinoma in European Union
Secondary Skin Cancer and BTK Inhibitors for CLL
ICML 2019: Improved Outcomes With Brentuximab Vedotin in Cutaneous Lymphoma
ICML 2019: Mogamulizumab in Cutaneous T-Cell Lymphoma
ASCO 2019: Treatment Patterns in Advanced Squamous Cell Carcinoma
ASCO 2019: Pembrolizumab for First-line Treatment of Unresectable Cutaneous Squamous Cell Carcinoma

By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.